Search results
Clinical trial leads to FDA approved treatment for peripheral artery disease
MinnPost· 1 day agoPeripheral artery disease or PAD, said Jennifer Jones-McMeans, Ph.D., divisional vice president of...
Avinger Increases Focus on Coronary Development, Reduces Operating Costs of Peripheral Business
Digital Journal· 7 hours agoAs part of this strategic prioritization, Avinger has reduced headcount dedicated to its peripheral business by 33%, which is expected to provide significant cost savings in the second half ...
Revolutionary Weight Loss: Largest Ever Obesity Study Showcases Semaglutide’s Promise
SciTechDaily· 5 days agoTwo important studies stemming from the largest and most prolonged clinical trial of semaglutide’s...
Concerning New Study Predicts Most U.S. Adults Will Have Cardiovascular Disease by 2050
Men's Journal· 23 hours agoThe research found that by 2050, clinical cardiovascular disease will affect 45 million adults in...
Do you really need compression socks on long flights?
San Francisco Chronicle· 3 hours agoSince the dawn of the jet age, travelers have been warned about the risks of dangerous blood clots while flying. In recent years, those warnings have often been accompanied by advice to wear ...
7 A-Rated Penny Stocks Worth Betting On in H2 2024
InvestorPlace· 6 days agoA-rated penny stocks could be ideal investment opportunities to help growth stock investors expand their portfolios. Penny stocks aren’t just a penny —...
Johnson & Johnson acquires Shockwave in $13.1bn deal
Medical Device Network via Yahoo Finance· 2 days agoShockwave specialises in coronary artery disease (CAD) and peripheral artery disease (PAD) treatments. Its core products are its intravascular ...
Author Zamone Perez | Navy Times
Navy Times· 2 days agoZamone “Z” Perez is a reporter at Military Times. He previously worked at Foreign Policy and Ufahamu Africa. He is a graduate of Northwestern University,...
J&J Completes Acquisition of Shockwave Medical
New Jersey Business Magazine· 5 days agoJohnson & Johnson completed its acquisition of Shockwave Medical, which will operate as a business unit within Johnson & Johnson MedTech.
Eden Prairie-based med-tech company Surmodics going private in $627M deal
Minneapolis-St. Paul Star Tribune· 7 days agoEden Prairie-based Surmodics' stock soared Wednesday following news of its impending sale that will...